Video

Advanced RNA-LNP Manufacturing Technology To Deliver High Quality Transformative Medicines

Source: Cytiva

Lipid nanoparticles are safe and effective for delivering nucleic acid drugs and are crucial to the success of mRNA vaccines and soon, other genomic medicines. Precision Nanosystems’ proprietary NxGen™ microfluidic technology available with the NanoAssemblr® Platforms enables controlled and precise assembly of high-quality, uniform LNPs, ensuring reproducible scale-up of RNA-LNPs while maximizing drug loading, particle quality, and the scope of compositions.

access the Video!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Advancing RNA? Subscribe today.

Subscribe to Advancing RNA X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Advancing RNA

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)

Cytiva